RPRX
Royalty Pharma PlcNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$31.60B
P/E Ratio
28.88
EPS
$1.90
Beta
0.42
52W High
$56.50
52W Low
$33.57
50-Day MA
$51.52
200-Day MA
$42.99
Dividend Yield
1.62%
Profit Margin
33.90%
Forward P/E
45.25
PEG Ratio
2.05
About Royalty Pharma Plc
Royalty Pharma plc is a buyer of biopharmaceutical royalties and funder of innovations in the biopharmaceutical industry in the United States. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | $2.44B |
| Gross Profit (TTM) | $2.81B |
| EBITDA | $1.56B |
| Operating Margin | 100.30% |
| Return on Equity | 13.80% |
| Return on Assets | 5.54% |
| Revenue/Share (TTM) | $5.67 |
| Book Value | $15.53 |
| Price-to-Book | 3.53 |
| Price-to-Sales (TTM) | 12.95 |
| EV/Revenue | 13.07 |
| EV/EBITDA | 18.77 |
| Quarterly Earnings Growth (YoY) | 23.20% |
| Quarterly Revenue Growth (YoY) | 11.00% |
| Shares Outstanding | $443.27M |
| Float | $410.34M |
| % Insiders | 7.17% |
| % Institutions | 85.81% |
Historical Volatility
HV 10-Day
25.25%
HV 20-Day
22.65%
HV 30-Day
21.75%
HV 60-Day
21.35%
HV Rank
67.9%
Volatility is currently expanding
Analyst Ratings
Consensus ($59.25 target)
3
Strong Buy6
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026